Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Dabomb Protein BiotechROCO:6578 -1.23%58 PB Ratio is 1.16 as of Jul. 29, 2026, which is 6% above its 10-year median of 1.09. GuruFocus rates ROCO:6578 with a GF Score™ of 58/100 and a GF Value™ of NT$16.63 (Fairly Valued). The stock has 1 warning sign investors should review. Among 1,899 Consumer Packaged Goods companies, Dabomb Protein Biotech ranks better than 56.03% on this metric.
Dabomb Protein Biotech Corp stock PB Ratio (=1.17) is close to 2-year low of 1.09.
The historical rank and industry rank for Dabomb Protein Biotech's PB Ratio or its related term are showing as below:
ROCO:6578'
s PB Ratio Range Over the Past 10 Years
Min: 0.69 Med: 1.09 Max: 1.93
Current: 1.16
During the past 13 years, Dabomb Protein Biotech's highest PB Ratio was 1.93. The lowest was 0.69. And the median was 1.09.
ROCO:6578's PB Ratio is ranked better than 56.03% of 1899
companies
in the Consumer Packaged Goods industry
Industry Median: 1.35
vs ROCO:6578: 1.16
During the past 12 months, Dabomb Protein Biotech's average Book Value Per Share Growth Rate was -8.90% per year.
During the past 3 years, the average Book Value Per Share Growth Rate was -9.30% per year.
During the past 5 years, the average Book Value Per Share Growth Rate was -8.00% per year.
During the past 10 years, the average Book Value Per Share Growth Rate was -4.00% per year.
During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of Dabomb Protein Biotech was 25.70% per year. The lowest was -9.30% per year. And the median was -1.70% per year.
Back to Basics: PB Ratio
Dabomb Protein Biotech (ROCO:6578) PB Ratio Explanation
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Packaged Foods subindustry, Dabomb Protein Biotech's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Dabomb Protein Biotech PB Ratio vs Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, Dabomb Protein Biotech's PB Ratio distribution charts can be found below:
* The bar in red indicates where Dabomb Protein Biotech's PB Ratio falls into.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
Dabomb Protein Biotech (ROCO:6578) has a PB Ratio of 1.16 as of Jul. 29, 2026. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Dabomb Protein Biotech and its competitors. This is near median its historical median of 1.09. Over the past decade, Dabomb Protein Biotech's PB Ratio has ranged from 0.69 to 1.93. According to the industry distribution chart, Dabomb Protein Biotech ranks #835 out of 1899 companies in the Consumer Packaged Goods industry, placing it in the top 44%.
Is Dabomb Protein Biotech's PB Ratio too high?
Dabomb Protein Biotech's current PB Ratio of 1.16 is near median its 10-year median of 1.09. Over the past 10 years, this metric has ranged from a low of 0.69 to a high of 1.93. The Consumer Packaged Goods industry median PB Ratio is 1.35. Dabomb Protein Biotech's value of 1.16 is 14.1% below this industry median. Based on the distribution chart, Dabomb Protein Biotech ranks #835 out of 1899 companies in the Consumer Packaged Goods industry, which is above the industry midpoint. Overall, Dabomb Protein Biotech has a GF Score™ of 58/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Dabomb Protein Biotech's PB Ratio compare to KHC and GIS?
According to the Consumer Packaged Goods industry distribution chart, Dabomb Protein Biotech ranks #835 out of 1899 companies for PB Ratio. This puts Dabomb Protein Biotech in the upper half of its industry. The industry median PB Ratio is 1.35. Dabomb Protein Biotech's value of 1.16 is 14.1% below this benchmark. Historically, Dabomb Protein Biotech's own PB Ratio has ranged from 0.69 to 1.93 over the past decade. While the company's 10-year median is 1.09 vs. the industry median of 1.35, Dabomb Protein Biotech has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PB Ratio for a Consumer Packaged Goods company?
The median PB Ratio among Consumer Packaged Goods companies is 1.35, based on 1,899 companies in the industry. Companies in the top quartile (top 25%) have a PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Dabomb Protein Biotech's current PB Ratio of 1.16 is 14.1% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PB Ratio mean?
A high PB Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Dabomb Protein Biotech and its competitors. For the Consumer Packaged Goods industry, the median PB Ratio is 1.35 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Dabomb Protein Biotech's current PB Ratio is 1.16, which is near median its own 10-year median of 1.09. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Dabomb Protein Biotech stock overvalued right now?
Based on GuruFocus' analysis, Dabomb Protein Biotech (ROCO:6578) is currently considered Fairly Valued. The stock's GF Value™ is NT$16.63, compared to a current price of NT$16.10 — trading 3.2% below its estimated fair value. The current PB Ratio is 1.16, which is near median its 10-year median of 1.09 and 14.1% below the Consumer Packaged Goods industry median of 1.35. Dabomb Protein Biotech's overall GF Score™ is 58/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PB Ratio calculated?
PB Ratio is calculated from a company's financial statements. For Dabomb Protein Biotech (ROCO:6578), the current PB Ratio is 1.16 as of Jul. 29, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Dabomb Protein Biotech (ROCO:6578) Overvalued in 2026?
Based on GuruFocus' analysis, Dabomb Protein Biotech stock appears to be undervalued.
The current stock price of NT$16.10 is trading 3.2% below its estimated GF Value™ of NT$16.63.
GuruFocus considers Dabomb Protein Biotech to be Fairly Valued.
Key valuation signals for ROCO:6578:
PB Ratio: 1.16 (near median its 10-year median of 1.09)
GF Value™: NT$16.63 vs. price of NT$16.10 (3.2% below fair value)
Industry Position: 14.1% below the Consumer Packaged Goods median (#835 of 1899)
No single metric tells the full story. See the ROCO:6578 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Dabomb Protein Biotech Corp is engaged in the manufacture, wholesale, and sale of hydrolyzed soy protein. The products of the company include Plant protein, Antibiotics alternatives, Pet care, Core technology, and CDMO(ODM/OEM). The company operates in a single segment engaged in the manufacture, wholesale and sales of hydrolysed soy protein. Geographically it operates in Malaysia, Taiwan, USA, Vietnam, and Others with majority of the revenue deriving from Vietnam.
58GF Score
Get the complete analysis for ROCO:6578
PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ROCO:6578 has been successfully added to your 
